EUVIMEDEUVIMED entdecken
KohortenstudieStudienprotokollOpen Access · CC BY 4.0

Protocol for a prospective observational cohort study to assess clinical applications of expanded noninvasive prenatal testing (NIPT) in pregnancies with placental dysfunction

Ana Villalba iD, M Ángeles Sánchez-Durán, Carmen Orellana, Mercedes Sobreviela, María M Gil, Rosa María Lobo, Irene Gómez-Manjón iD, Cristina Cea, Laia Pedrola Vidal iD, Sebastian Menao, Raquel Martin-Alonso, Gonzalo E Quesada und 15 weitere

PLOS One · 09.04.2026 · 21 (4) · e0344772

DOI: 10.1371/journal.pone.0344772 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS One, online erschienen am 09.04.2026. Verfasst von Ana Villalba und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Hospital Universitario 12 de Octubre, Madrid, Spain. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Noninvasive Prenatal Testing, Placenta, Placenta Diseases. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Union though the Next Generation EU funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction Expanded non-invasive prenatal testing (NIPT) utilizing cell-free DNA (cfDNA) in maternal blood enables the detection of common trisomies as well as rare autosomal trisomies and large deletions and duplications within the genome of the placenta and, therefore, the fetus. Given that cfDNA predominantly originates from trophoblastic cells, expanded NIPT also holds the potential to reveal confined placental mosaicism (CPM). CPM has been associated with placental dysfunction, which can result in reduced levels of the circulating placental biomarkers routinely tested as part of first-trimester aneuploidy screening and in early-onset fetal growth restriction (eoFGR). This study aims to explore whether expanded NIPT adds clinical value compared with targeted NIPT in pregnancies exhibiting placental dysfunction, which is proxied herein by first-trimester pregnancy-associated plasma protein A (PAPP-A) or the beta-subunit of human chorionic gonadotropin (β-hCG) values

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal Growth RetardationNoninvasive Prenatal TestingPlacentaPlacenta DiseasesAdultFemaleHumansPregnancyBiomarkersCell-Free Nucleic AcidsChorionic Gonadotropin, beta Subunit, HumanMosaicismPregnancy Trimester, FirstPregnancy-Associated Plasma Protein-AProspective StudiesMulticenter Studies as TopicObservational Studies as Topic

Substanzen

BiomarkersCell-Free Nucleic AcidsChorionic Gonadotropin, beta Subunit, HumanPregnancy-Associated Plasma Protein-A

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Department of Obstetrics, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Departament de Pediatria, Obstetrícia i Ginecologia i de Medicina Preventiva i Salut Pública, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Genetics Unit, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Department of Obstetrics, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
  • Aragon Institute of Health Research (IIS Aragon), Zaragoza, Spain.

ORCID-Profile: Ana Villalba, Irene Gómez-Manjón, Laia Pedrola Vidal, Alberto Galindo, Manel Mendoza, Daniela Piazzolla, Francisco Javier Fernández, Ignacio Herraiz

Förderung

  • Instituto de Salud Carlos III
  • European Union though the Next Generation EU funds

Zitieren

APA

Villalba, A., Sánchez-Durán, M. Á., Orellana, C., Sobreviela, M., Gil, M. M., Lobo, R. M., Gómez-Manjón, I., Cea, C., Pedrola Vidal, L., Menao, S., Martin-Alonso, R., Quesada, G. E., Albuixech, E., Roselló Piera, M., Valle, E., Tizzano, E., Galindo, A., Mendoza, M., Marcos, B., …, & Herraiz, I. (2026). Protocol for a prospective observational cohort study to assess clinical applications of expanded noninvasive prenatal testing (NIPT) in pregnancies with placental dysfunction. PLOS One, 21(4), e0344772. https://doi.org/10.1371/journal.pone.0344772

Vancouver

Villalba A, Sánchez-Durán MÁ, Orellana C, Sobreviela M, Gil MM, Lobo RM, et al. Protocol for a prospective observational cohort study to assess clinical applications of expanded noninvasive prenatal testing (NIPT) in pregnancies with placental dysfunction. PLOS One. 2026;21(4):e0344772. doi:10.1371/journal.pone.0344772

BibTeX
@article{Villalba2026,
  author = {Villalba, Ana and Sánchez-Durán, M Ángeles and Orellana, Carmen and Sobreviela, Mercedes and Gil, María M and Lobo, Rosa María and Gómez-Manjón, Irene and Cea, Cristina and Pedrola Vidal, Laia and Menao, Sebastian and Martin-Alonso, Raquel and Quesada, Gonzalo E and Albuixech, Eva and Roselló Piera, Mónica and Valle, Eva and Tizzano, Eduardo and Galindo, Alberto and Mendoza, Manel and Marcos, Beatriz and Cervera, José Vicente and Santacruz, Belén and Piazzolla, Daniela and Page-Christiaens, Lieve and Lerma, Diego and Quiroga, Ramiro and Fernández, Francisco Javier and Herraiz, Ignacio},
  title = {Protocol for a prospective observational cohort study to assess clinical applications of expanded noninvasive prenatal testing (NIPT) in pregnancies with placental dysfunction},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {e0344772},
  doi = {10.1371/journal.pone.0344772}
}
Kostenlos starten →